CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis

Journal of Hepatology

Volumn 32, Issue 4, 2000, Pages 538-541

  Agarwal, Kosh ^a   Jones, David E J ^a   Daly, Ann K ^a   James, Oliver F W ^a   Vaidya, Bijayesirar ^b   Pearce, Simon ^b   Bassendine, Margaret F ^a  

^a Centre for Liver Research   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Autoimmunity; Biliary; CTLA 4; Genetics; Liver; Liver cirrhosis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CHOLESTASIS; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOREGULATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0034070032     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80213-5     Document Type: Article

References (34)

1. Metcalf JV, Bhopal RS, Gray J, Howel D, James OFW. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol. 26:1997;830-836.
2. Neuberger J. Primary biliary cirrhosis. Lancet. 350:1997;875-879.
3. Bassendine MF, Jones OFW, Yeaman SJ. Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis. Semin Liver Dis. 17:1997;49-60.
4. Joplin R, Gordon Lindsay J, Johnson GD, Strain A, Neuberger J. Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. Lancet. 339:1992;93-94.
5. Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut. 36:1995;615-617.
6. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell. 85:1996;311-318.
7. Jones DEJ, Watt FE, Metcalf JV, Bassendine MF, James OFW. Familial primary biliary cirrhosis reassessed: a geographicallybased population study. J Hepatol. 30:1999;402-407.
8. Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci USA. 92:1995;8560-8565.
9. Underhill J, Donaldson P, Bray G, Doherty D, Portmann B, Williams R. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology. 16:1992;1404-1408.
10. Gregory WL, Mehal W, Dunn AN, Cavanagh G, Chapman R, Fleming KA, et al. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q J Med. 86:1993;393-399.
11. Onishi S, Sakamaki T, Maeda T, Iwamura S, Tomita A, Saibara T, et al. DNA typing of HLA class II genes: DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol. 21:1994;1053-1060.
12. Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, Gershwin ME. Genes within HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens. 43:1994;71-77.
13. Mehal WZ, Gregory WL, Lo Y-MD, Cross SJ, Fleming KA, Bassendine MF, et al. Defining the immunogenetic suceptibility to primary biliary cirrhosis. Hepatology. 20:1994;1213-1219.
14. Jones DEJ. T-cell autoimmunity in primary biliary cirrhosis. Clin Sci. 91:1996;551-558.
15. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity. 7:1997;445-450.
16. Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol. 158:1997;1989-1993.
17. Nistico L, Buzzeti R, Pritchard LE, Van Der Auwera BJ, Giovannini C, Bosi E, et al. The CTLA-4 region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet. 5:1996;1075-1080.
18. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Larred MTM, et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA-4 polymorphisms in multiple ethnic groups. Hum Mol Genet. 6:1997;1275-1282.
19. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke A, et al. CTLA-4 alanine-17 confers genetic susceptiblity to Graves' disease and to Type 1 diabetes mellitus. J Clin Endocrinol Metabol. 82:1997;143-146.
20. Van der Auwera J, Vandewalle CL, Schuit FC, Winnock F, De Leeuw IH, Van Imschoot S, et al. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. Clin Exp Immunol. 110:1997;98-103.
21. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, et al. CTLA-4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid. 7:1997;843-846.
22. Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, Ishii C, et al. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes. 47:1998;128-129.
23. Crowe JP, Christensen E, Butler J, Wheeler P, Doniach D, Keenan J, et al. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroidautoantibodies and Sicca syndrome. Gastroenterology. 78:1980;1437-1441.
24. Editorial. Freely associating. Nat Genet. 22:1999;1-2.
25. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet. 59:1996;983-989.
26. Becker KG, Simon RM, Bailey-Wilson JE, Friedlin B, Biddison WE, McFarland HF, et al. Clustering of non-major histocompatibility complex susceptibility loci in human autoimmune diseases. Proc Nat Acad Sci USA. 95:1998;9979-9984.
27. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science. 270:1995;985-988.
28. Luhder F, Hoglund P, Allison JP, Benoist C, Mathis D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J Exp Med. 187:1998;427-432.
29. Perrin PJ, Maldonado JH, Davis TA, June CH, Racke MK. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J Immunol. 157:1996;1333-1336.
30. Bassendine MF, Palmer JM, DeCruz D, McCaughan GW, Strickland D, Sedgewick JD, et al. Approaches to a murine model of AMA positive non-suppurative destructive cholangitis. [abstract] J Hepatol. 28:1998;124.
31. Abrams JR, Lebwohl MG, Guzzo CA, Jagasothy BV, Goldfarb MT, Goffe BS, et al. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest. 103:1999;1243-1252.
32. Yeaman SJ, Fussey SP, Danner DJ, James OFW, Bassendine MF. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet. i:1988;1067-1070.
33. Shimoda S, Nakamura M, Ishibishi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T-cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune disease. J Exp Med. 181:1995;1835-1845.
34. Becker KG. Comparative genetics of type 1 diabetes and autoimmune disease. Diabetes. 48:1999;1353-1358.